US Patent

US9066856 — Stable preservative-free mydriatic and anti-inflammatory solutions for injection

Formulation · Assigned to Omeros Medical Systems Inc · Expires 2033-10-23 · 7y remaining

Vulnerability score 42/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects stable, preservative-free liquid formulations of phenylephrine and ketorolac for injection.

USPTO Abstract

The present invention relates to stable, preservative- and antioxidant-free liquid formulations of phenylephrine and ketorolac for injection.

Drugs covered by this patent

Patent Metadata

Patent number: US9066856
Jurisdiction: US
Classification: Formulation
Expires: 2033-10-23
Drug substance claim: No
Drug product claim: Yes
Assignee: Omeros Medical Systems Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.